Skip to main content
TipRanks
Go Ultimate75% OFF

TaiGen Biopharmaceuticals Holdings Limited (4157) Q2 2025 Earnings Report

TW:4157 Q2 2025 EPS Results

Actual EPS
-TWD 0.17
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
TWD 0.09

TW:4157 Q2 2025 Revenue Results

Actual Revenue
TWD 10.70M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-91.19%

Earnings Announcement Details

Quarter
Q2 2025
Date
08/20/2025
Time
Before Open
Conference Call
Wednesday, August 20, 2025
TW:4157 Upcoming Earnings

TaiGen Biopharmaceuticals Holdings Limited's next earnings date is estimated for March 18, 2027, based on past reporting schedules.

Q2 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:4157 Earnings History

TW:4157 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 18, 20272026 (Q4)―-0.29――
Nov 18, 20262026 (Q3)―-0.02-0.02-15.00% (-0.00)
Aug 26, 20262026 (Q2)―-0.03-0.1782.46% (+0.14)
May 12, 20262026 (Q1)―-0.02-0.0337.50% (+0.01)
Mar 13, 20262025 (Q4)―0.29-0.03947.06% (+0.32)
Nov 13, 20252025 (Q3)―-0.02-0.180.00% (+0.08)
Aug 20, 20252025 (Q2)―-0.170.09-290.00% (-0.26)
May 14, 20252025 (Q1)―-0.03-0.01-255.56% (-0.02)
Mar 13, 20252024 (Q4)―-0.030.26-113.13% (-0.29)
Nov 13, 20242024 (Q3)―-0.10-0.01-733.33% (-0.09)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed